January 2026
The clinical trials matching software market size is projected to hit around USD 603.48 million by 2035 from USD 208.52 million in 2025 with a CAGR of 11.21%.
September 2026
The mental health clinical trials market size was valued at USD 3.72 billion in 2026 and is projected to surge around USD 7.00 billion by 2034, with a CAGR of 8.24%.
September 2026
The neurology clinical trials market size was valued at USD 6.57 billion in 2026 and is projected to reach around USD 10.14 billion by 2034 with a CAGR of 5.58%.
September 2026
The global cardiovascular clinical trials market size was valued at USD 6.68 billion in 2026 and is expected to hit around USD 10.62 billion by 2034, growing at a CAGR of 5.98%.
September 2026
The global clinical trials market size is calculated at USD 91.66 billion in 2026 and is projected to hit around USD 158.92 billion by 2035, with a solid CAGR of 6.15%.
September 2026
The global oncology clinical trials market size is expected to worth around USD 22.76 billion by 2034 from USD 13.60 billion in 2024 with a CAGR of 5.28%.
September 2026
The biopharma clinical trials market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
September 2026
The generative AI in clinical trials market size was USD 303.39 billion in 2026, with leading generative AI in clinical trials market players including IBM, Microsoft, Google Health, IQVIA, Parexel, ICON plc.
September 2026
The global large-scale active stem cell clinical trials market size was evaluated at USD 8.27 billion in 2026 and is predicted to hit around USD 28.88 billion by 2035, growing at a CAGR of 14.90%.
September 2026
The decentralized clinical trials in neurology market size reached USD 1.71 billion in 2026, with leading decentralized clinical trials in neurology market companies including IQVIA, ICON plc, Parexel, Medpace.
September 2026
The CNS clinical trials market size reached USD 9.33 billion in 2026, with leading CNS clinical trials market companies including IQVIA, ICON plc, Labcorp Drug Development, Syneos Health.
August 2026
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%
August 2026
The U.S. clinical trials market size is valued at USD 47.18 billion in 2025 and is projected to hit around USD 88.16 billion by 2035 with a CAGR of 6.45%.
July 2026
The global AI in clinical trials market size was exhibited at USD 2.60 billion in 2025 and is projected to hit around USD 25.52 billion by 2035, with a remarkable CAGR of 25.66%.
June 2026
The global medical device clinical trials market size was evaluated at USD 17.74 billion in 2025 and is predicted to hit around USD 32.25 billion by 2035, growing at a CAGR of 6.16%.
June 2026
The virtual clinical trials market size is calculated at USD 11.26 billion in 2025 and is projected to hit around USD 18.40 billion by 2035 with a CAGR of 5.03%.
June 2026
The atopic dermatitis clinical trials market size is evaluated at USD 3.04 billion in 2025 and is expected to attain around USD 8.39 billion by 2035 with a CAGR of 10.69%.
March 2026
The global clinical trials support services market size was estimated at USD 27.09 billion in 2025 and is expected to hit around USD 57.45 billion by 2035, at a CAGR of 7.81%.
February 2026
The global AI-based clinical trials solution provider market size is estimated to surpass around USD 20.17 billion by 2035 from USD 2.88 billion in 2025, at a CAGR of 21.49%.
December 2025
The global clinical trials site management organizations market size is projected to hit around USD 14.75 billion by 2035 from USD 7.74 billion in 2025 with a CAGR of 6.66%
December 2025
The global omics-based clinical trials market size is evaluated at USD 35.71 billion in 2025 and is predicted to hit around USD 78.03 billion by 2035, growing at a CAGR of 8.13%.
December 2025
The global preclinical and clinical trials market growth is fueled by biotech innovation, regulatory needs, and advanced testing technologies.
July 2025
The RNA therapy clinical trials market size was valued at USD 3.05 billion in 2026 and is expected to hit around USD 4.11 billion by 2034 with a CAGR of 3.84%.
September 2026
The preclinical CRO market size was valued at USD 7.29 billion in 2026 and is expected to hit around USD 14.01 billion by 2035, growing at a CAGR of 7.56%.
September 2026
The global clinical communication and collaboration market size was valued at USD 2.84 billion in 2026 and is projected to hit around USD 7.37 billion by 2035, expanding at a CAGR of 11.24%.
September 2026
The clinical laboratory service market size reached USD 334.25 billion in 2026, with leading clinical laboratory service market companies including Qiagen, Quest Diagnostics, Inc, OPKO Health, Inc.
September 2026
The global clinical nutrition market size is expected to increase from USD 35.93 billion in 2026 to hit around USD 57.34 billion by 2035, with a CAGR of 5.34%.
September 2026
The global anti-money laundering software market size is projected to hit around USD 10.74 billion by 2035 from USD 4.27 billion in 2026 with a CAGR of 10.83%.
September 2026
The clinical decision support systems market size is predicted to hit around USD 8.70 billion by 2035 from USD 4.28 billion in 2026 with a CAGR of 8.22%.
September 2026
The global teleradiology software market size is projected to hit around USD 12.78 billion by 2034 from USD 6.65 billion in 2026 and registering a CAGR of 8.50%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com